- Home
- STK vs QTRX Comparison
STK vs QTRX Comparison
Compare STK & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STK
- QTRX
- Stock Information
- Founded
- STK 2009
- QTRX 2007
- Country
- STK United States
- QTRX United States
- Employees
- STK N/A
- QTRX N/A
- Industry
- STK Investment Managers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- STK Finance
- QTRX Industrials
- Exchange
- STK Nasdaq
- QTRX Nasdaq
- Market Cap
- STK 545.5M
- QTRX 492.0M
- IPO Year
- STK N/A
- QTRX 2017
- Fundamental
- Price
- STK $31.94
- QTRX $12.89
- Analyst Decision
- STK
- QTRX Strong Buy
- Analyst Count
- STK 0
- QTRX 4
- Target Price
- STK N/A
- QTRX $23.00
- AVG Volume (30 Days)
- STK 38.2K
- QTRX 345.2K
- Earning Date
- STK 01-01-0001
- QTRX 11-04-2024
- Dividend Yield
- STK 6.60%
- QTRX N/A
- EPS Growth
- STK N/A
- QTRX N/A
- EPS
- STK N/A
- QTRX N/A
- Revenue
- STK N/A
- QTRX $129,330,000.00
- Revenue This Year
- STK N/A
- QTRX $13.56
- Revenue Next Year
- STK N/A
- QTRX $16.70
- P/E Ratio
- STK N/A
- QTRX N/A
- Revenue Growth
- STK N/A
- QTRX 15.52
- 52 Week Low
- STK $24.95
- QTRX $10.50
- 52 Week High
- STK $34.31
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- STK 49.22
- QTRX 49.71
- Support Level
- STK $30.88
- QTRX $11.53
- Resistance Level
- STK $32.27
- QTRX $13.04
- Average True Range (ATR)
- STK 0.60
- QTRX 0.63
- MACD
- STK -0.00
- QTRX 0.06
- Stochastic Oscillator
- STK 41.54
- QTRX 50.00
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.